Crossmark

Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study

Published Online: 2026-01-20

Published Print: 2026-01

Authors

Stabellini, Nickolas

Kaur, Jasskiran

Owusu, Cynthia

Moftakhar, Bahar

Mizukami, Takae

de Oliveira, Sonia D.

Montero, Alberto J.
License Information

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2026-01-20
More Information

Article History

Received: 16 October 2025

Accepted: 29 December 2025

First Online: 20 January 2026

Declarations

:

: The authors declare no competing interests.

Document is current